ŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰ο
‰οˆυƒƒOƒCƒ“ ‘γ•\ˆ₯ŽA
‘‰οEŠwpW‰ο
Šw‰οŽ
’θŠΌ
Œφ
—˜‰v‘Š”½
–πˆυ\¬
Ž––±‹ΗˆΔ“ΰ
‹lŽ{έˆκ——
ŠΦ˜AƒŠƒ“ƒN

@ŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰ο‰οŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹

<< Šw‰οŽ‚Φ–ί‚ι
<< ‘O‚Μƒy[ƒW‚Φ–ί‚ι

y“ΑWz
ƒƒ\ƒgƒŒƒLƒZ[ƒg“Š—^’†‚ΙStevens-JohnsonΗŒσŒQ‚π’ζ‚΅‚½“]ˆΪ«EN“όŠο‘Ω‚Μˆκ—α


—±—ˆ@‘ρ, ²“‘@”ό‹IŽq, “ޗǁ@ˆŸ‹MŽq, ‘ˆδ@ˆκΝ, Β–؁@–Ξ, •‹@–ƒ‹I, ˆΐ“‘@‹IŽq, ‚ˆΐ@‹`O, –Ξ“c@”Žs
‰‘•lŽs—§Žs–―•a‰@ŽY•wl‰Θ


Key wordsFGestational trophoblastic disease, Stevens-Johnson syndrome, Methotrexate

“ϊ–{ŽY‰Θ•wl‰ΘŠw‰οŠΦ“Œ˜A‡’n•ϋ•”‰ο‰οŽ, 47(4) 459-463, 2010


ˆκ”ΚŽΠ’c–@lŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰οŽ––±‹Η@§102-0083 “Œ‹ž“sη‘γ“c‹ζ’¬4-7 ’¬ƒp[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“ΰ
TELF03-3288-0993@FAXF03-5275-1192@E-mailFkantorengo@jsog-k.jp
Copyright (C) ˆκ”ΚŽΠ’c–@lŠΦ“Œ˜A‡ŽY‰Θ•wl‰ΘŠw‰ο